14 hasil untuk ". Alimuddin"
Menampilkan 1–14 · 0,40 detik · RSS
-
Artikel Jurnal Teks lengkap
Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses
Coronaviruses (CoVs) are a large family of enveloped, positive-strand RNA viruses. Four human CoVs (HCoVs), the non-severe acute respiratory syndrome (SARS)-like HCoVs (namely HCoV 229E, NL63, OC43, and HKU1), are globally endemic and account for a substantial fraction of upper respiratory tract…
-
Artikel Jurnal Teks lengkap
Reducing mortality from 2019-nCoV: host-directed therapies should be an option
Dari koleksi institusi
- orang mandar orang lautMuhammad Ridwan Alimuddin · 2005 · UNILAK
- Orang Mandar orang laut : kebudayaan bahari Mandar mengarungi gelombang perubahan zamanMuhammad Ridwan Alimuddin · 2005 · Universitas Riau (UNRI)
-
Artikel Jurnal Teks lengkap
The WHO Global Tuberculosis 2021 Report – not so good news and turning the tide back to End TB
OBJECTIVE: To review the data presented in the 2021 WHO global TB report and discuss the current constraints in the global response. INTRODUCTION AND METHODS: The WHO global TB reports, consolidate TB data from countries and provide up to date assessment of the global TB epidemic. We reviewed the…
-
Artikel Jurnal Teks lengkap
The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China
The city of Wuhan in China is the focus of global attention due to an outbreak of a febrile respiratory illness due to a coronavirus 2019-nCoV. In December 2019, there was an outbreak of pneumonia of unknown cause in Wuhan, Hubei province in China, with an epidemiological link to the Huanan Seafood…
-
Artikel Jurnal Teks lengkap
Global Tuberculosis Report 2020 – Reflections on the Global TB burden, treatment and prevention efforts
The October 2020 Global TB report reviews TB control strategies and United Nations (UN) targets set in the political declaration at the September 2018 UN General Assembly high-level meeting on TB held in New York. Progress in TB care and prevention has been very slow. In 2019, TB remained the most…
-
Artikel Jurnal Teks lengkap
Single-cell landscape of immunological responses in patients with COVID-19
-
Artikel Jurnal Teks lengkap
Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial
Abstract No effective drug treatments are available for coronavirus disease 2019 (COVID-19). Host-directed therapies targeting the underlying aberrant immune responses leading to pulmonary tissue damage, death, or long-term functional disability in survivors require clinical evaluation. We…
-
Artikel Jurnal Teks lengkap
Immunological and inflammatory profiles in mild and severe cases of COVID-19
COVID-19 is associated with 5.1% mortality. Although the virological, epidemiological, clinical, and management outcome features of COVID-19 patients have been defined rapidly, the inflammatory and immune profiles require definition as they influence pathogenesis and clinical expression of…
-
Artikel Jurnal Teks lengkap
Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19)
SARS-CoV-2 is associated with a 3.4% mortality rate in patients with severe disease. The pathogenesis of severe cases remains unknown. We performed an in-depth prospective analysis of immune and inflammation markers in two patients with severe COVID-19 disease from presentation to convalescence…
-
Artikel Jurnal Teks lengkap
Lockdown measures in response to COVID-19 in nine sub-Saharan African countries
Lockdown measures have been introduced worldwide to contain the transmission of COVID-19. However, the term 'lockdown' is not well-defined. Indeed, WHO's reference to 'so-called lockdown measures' indicates the absence of a clear and universally accepted definition of the term 'lockdown'. We…
-
Artikel Jurnal Teks lengkap
Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial
Abstract Treatment of severe Coronavirus Disease 2019 (COVID-19) is challenging. We performed a phase 2 trial to assess the efficacy and safety of human umbilical cord-mesenchymal stem cells (UC-MSCs) to treat severe COVID-19 patients with lung damage, based on our phase 1 data. In this randomized…
-
Artikel Jurnal Teks lengkap
MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network
The continuous flow of new research articles on MDR-TB diagnosis, treatment, prevention and rehabilitation requires frequent update of existing guidelines. This review is aimed at providing clinicians and public health staff with an updated and easy-to-consult document arising from consensus of…